St. Jude Medical Announces Expanded European CE Mark to Include Therapy Cool Path Bi-Directional Irrigated Ablation Catheter; U.S. Approval for Therapy Cool Path Irrigated Ablation Catheter

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today announced expanded European CE Mark approval to include the Therapy™ Cool Path™ irrigated ablation catheter with bi-directional steering for use in ablation procedures to treat abnormal heart rhythms. This catheter is the first open-irrigated ablation catheter to provide bi-directional steering, a feature designed to help physicians maneuver the catheter in difficult areas of the heart and perform complex ablations more efficiently.